IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SUARDI, NAZARENO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.763
AS - Asia 6.331
SA - Sud America 2.417
EU - Europa 1.951
Continente sconosciuto - Info sul continente non disponibili 320
AF - Africa 172
OC - Oceania 12
AN - Antartide 1
Totale 20.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.327
SG - Singapore 2.505
BR - Brasile 1.998
CN - Cina 1.071
HK - Hong Kong 1.022
VN - Vietnam 616
GB - Regno Unito 340
IT - Italia 311
RU - Federazione Russa 308
TR - Turchia 308
FR - Francia 302
BD - Bangladesh 272
IE - Irlanda 242
CA - Canada 216
AR - Argentina 170
IN - India 134
DE - Germania 120
IQ - Iraq 75
EC - Ecuador 74
MX - Messico 74
ID - Indonesia 66
CO - Colombia 56
SE - Svezia 54
ZA - Sudafrica 53
FI - Finlandia 49
UA - Ucraina 41
SA - Arabia Saudita 37
PK - Pakistan 33
ES - Italia 32
JM - Giamaica 28
PY - Paraguay 27
VE - Venezuela 27
CL - Cile 25
CR - Costa Rica 25
KE - Kenya 21
NL - Olanda 21
MA - Marocco 20
PH - Filippine 20
PL - Polonia 20
TN - Tunisia 19
EE - Estonia 18
HN - Honduras 18
AT - Austria 17
JP - Giappone 17
UY - Uruguay 17
JO - Giordania 16
UZ - Uzbekistan 16
EG - Egitto 15
AE - Emirati Arabi Uniti 14
PE - Perù 14
NI - Nicaragua 13
NP - Nepal 13
TT - Trinidad e Tobago 13
AU - Australia 11
AZ - Azerbaigian 11
BB - Barbados 11
DZ - Algeria 11
KZ - Kazakistan 11
CZ - Repubblica Ceca 10
BH - Bahrain 9
LB - Libano 9
IL - Israele 8
PT - Portogallo 8
CH - Svizzera 7
OM - Oman 7
SN - Senegal 7
AL - Albania 6
BO - Bolivia 6
ET - Etiopia 6
RS - Serbia 6
BE - Belgio 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
LT - Lituania 5
MY - Malesia 5
PA - Panama 5
PR - Porto Rico 5
SV - El Salvador 5
TH - Thailandia 5
AM - Armenia 4
BG - Bulgaria 4
GE - Georgia 4
GR - Grecia 4
LV - Lettonia 4
SY - Repubblica araba siriana 4
AO - Angola 3
CG - Congo 3
CI - Costa d'Avorio 3
DK - Danimarca 3
HU - Ungheria 3
KW - Kuwait 3
MK - Macedonia 3
NG - Nigeria 3
XK - ???statistics.table.value.countryCode.XK??? 3
BM - Bermuda 2
BS - Bahamas 2
BW - Botswana 2
GD - Grenada 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
Totale 20.612
Salva come PNG Salva come JPEG
Città #
Singapore 1.233
Hong Kong 1.022
Ashburn 1.004
San Jose 810
The Dalles 497
Princeton 486
Council Bluffs 472
New York 463
Los Angeles 315
Dallas 297
Istanbul 280
Lauterbourg 269
Dublin 245
Ho Chi Minh City 214
Beijing 181
Fairfield 150
Santa Clara 150
São Paulo 139
Moscow 138
Redondo Beach 135
Hanoi 134
Des Moines 130
San Diego 127
Wilmington 124
Orem 123
London 122
Buffalo 118
Seattle 112
Houston 108
San Francisco 103
Chicago 96
North Bergen 92
Denver 71
Columbus 70
Atlanta 67
Brooklyn 66
Phoenix 64
Rio de Janeiro 59
Woodbridge 56
Brasília 43
Toronto 43
Milan 42
Montreal 42
Belo Horizonte 36
Cambridge 35
Porto Alegre 33
Guayaquil 32
Rome 31
Helsinki 30
Curitiba 29
Shanghai 29
Chandler 28
Chennai 28
Munich 28
Romola 28
Salvador 27
Manchester 26
Philadelphia 25
Boston 24
Campinas 24
Johannesburg 24
Nuremberg 24
Biên Hòa 22
Erbil 22
Buenos Aires 20
Guarulhos 20
Haiphong 20
Miami 20
Warsaw 20
Tianjin 19
Baghdad 18
Charlotte 18
Da Nang 18
Fortaleza 18
Nairobi 18
Quito 18
San José 18
Bogotá 17
Goiânia 17
Hải Dương 17
Thái Bình 17
Jacksonville 16
Manaus 16
Naples 16
Riyadh 16
West Jordan 16
Milwaukee 15
Newark 15
Raleigh 15
Recife 15
Salt Lake City 15
Amman 14
Ankara 14
Bắc Giang 14
Campo Grande 14
Cincinnati 14
Cleveland 14
Dhaka 14
Jakarta 14
Kingston 14
Totale 11.691
Salva come PNG Salva come JPEG
Nome #
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium 2.313
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 184
Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration 148
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial 123
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 119
Evaluating Lichen Sclerosus in Phimosis: Insights From a Multidisciplinary Retrospective Study 115
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy 114
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 113
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 110
A proposal of a new nomogram for predicting upstaging in contemporary D’Amico low-risk prostate cancer patients 107
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide 103
A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients 102
Salvage lymph node dissection: if yes, robotics? 101
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 97
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites 96
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation 95
Population-based Analysis of Normal Total PSA and Percentage of Free/Total PSA Values: Results From Screening Cohort 93
Management of osteomyelitis of the pubic symphysis following urinary fistula in patients with radiation-induced urethral strictures after prostate cancer treatment 90
A nomogram predicting long-term biochemical recurrence after radical prostatectomy 90
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 90
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 90
A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia 88
Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy 87
Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review 86
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review 85
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity 85
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer 81
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration 81
A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma 81
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 81
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy 80
A Nomogram Predicting Prostate Cancer-Specific Mortality after Radical Prostatectomy 80
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 79
A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy 79
A robotic needle driver to facilitate vescico-urethral anastomosis during laparoscopic radical prostatectomy 77
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy 77
Port-site metastasis and atypical recurrences after robotic-assisted radical cystectomy (RARC): an updated comprehensive and systematic review of current evidences 77
A nomogram predicting metastatic progression after radical prostatectomy 77
Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment 77
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival 76
Micropapillary bladder cancer: an evolving biology 76
Benign Prostatic Hyperplasia and Its Aetiologies 76
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study 76
THE RATE OF SECONDARY MALIGNANCIES AFTER RADICAL PROSTATECTOMY VERSUS EXTERNAL BEAM RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: A POPULATION-BASED STUDY ON 17,845 PATIENTS 75
ABLATE: a score to predict complications and recurrence rate in percutaneous treatments of renal lesions 73
Response to Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients 73
Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens? 73
The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance-Implication for Clinical Decision Making in the Real-life Setting 73
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer 73
Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy 73
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients 73
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series 72
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis 71
Genitourinary manifestations of Lynch syndrome in the urological practice 71
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: A critical analysis of the literature 71
Prediction of delayed graft function after renal transplantation 71
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy 71
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer 71
Intensive simulation training on urological mini-invasive procedures using Thiel-embalmed cadavers: The IAMSurgery experience 70
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 70
Current Standard Technique for Modern Flexible Ureteroscopy: Tips and Tricks 70
The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy 69
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes? 69
Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study 68
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 67
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites 67
Assessing the Impact of Surgeon Experience on Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy: Results of Four High-Volume Surgeons 67
External Validation of the European Association of Urology Recommendations for Pelvic Lymph Node Dissection in Patients Treated with Robot-Assisted Radical Prostatectomy 67
Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2-4 pN+ Prostate Cancer: Results of a Matched Analysis 67
The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer 66
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm 66
External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients 66
Impact of Lymph Node Dissection on Cancer Specific Survival in Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy 66
Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis 66
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening 66
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy 65
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 65
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: A population-based study of 6183 men 65
When to perform preoperative chest computed tomography for renal cancer staging 65
Underestimation of positron emission tomography/computerized tomography in assessing tumor burden in prostate cancer nodal recurrence: Head-to-head comparison of 68Ga-PSMA and 11C-choline in a large, multi-institutional series of extended salvage lymph node dissections 65
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients 65
Prostate Saturation Biopsy following a First Negative Biopsy: State of the Art 65
Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer 65
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 65
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 64
The Role of Prostate-specific Antigen Persistence after Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients 64
Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features 64
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer 63
Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis 63
More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer 63
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy 63
Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma 63
‘En Bloc’ HoLEP with early apical release in men with benign prostatic hyperplasia 63
The Tomato Model 62
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men 62
The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance-Implication for Clinical Decision Making in the Real-life Setting REPLY 62
Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer 62
Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy 62
A novel tool to assess the risk of urinary incontinence after nerve-sparing radical prostatectomy 62
The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: Conditional survival analysis 62
Totale 10.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 160.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.301 0 0 0 0 0 560 38 70 60 195 131 247
2022/2023668 242 1 0 3 13 258 0 11 99 5 22 14
2023/20241.371 16 9 23 25 19 244 75 6 593 22 12 327
2024/20253.684 9 4 43 392 654 316 178 42 429 449 774 394
2025/202610.931 641 1.322 916 1.770 567 302 1.085 283 441 805 2.374 425
2026/20272.903 390 528 767 1.218 0 0 0 0 0 0 0 0
Totale 20.967